Maternal vaccines

被引:15
作者
Glezen, WP
机构
[1] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA
来源
PRIMARY CARE | 2001年 / 28卷 / 04期
关键词
D O I
10.1016/S0095-4543(05)70041-5
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Acute lower respiratory illness (LRI) is the leading cause of disease worldwide as measured by disability-adjusted life years. New strategies are necessary to decrease the disease burden that is largely borne by infants. Respiratory syncytial virus is the most important cause of LRI in infants. Lower respiratory illness can be prevented by endowing infants with high levels of neutralizing antibodies from mothers whose antibodies are boosted during pregnancy with a potent subunit vaccine. Another important cause of infant mortality is group B streptococcus sepsis in the neonatal period; maternal immunization with a group B conjugate vaccine could prevent this devastating infection.
引用
收藏
页码:791 / +
页数:18
相关论文
共 85 条
[1]  
AABY P, 1994, B WORLD HEALTH ORGAN, V72, P761
[2]   LONG-TERM SURVIVAL AFTER EDMONSTON-ZAGREB MEASLES VACCINATION IN GUINEA-BISSAU - INCREASED FEMALE MORTALITY-RATE [J].
AABY, P ;
KNUDSEN, K ;
WHITTLE, H ;
LISSE, IM ;
THAARUP, J ;
POULSEN, A ;
SODEMANN, M ;
JAKOBSEN, M ;
BRINK, L ;
GANSTED, U ;
PERMIN, A ;
JENSEN, TG ;
ANDERSEN, H ;
DASILVA, MC .
JOURNAL OF PEDIATRICS, 1993, 122 (06) :904-908
[3]   FETAL-NEONATAL PASSIVE-IMMUNIZATION AGAINST HEMOPHILUS-INFLUENZAE, TYPE-B [J].
AMSTEY, MS ;
INSEL, R ;
MUNOZ, J ;
PICHICHERO, M .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1985, 153 (06) :607-611
[4]  
Baker C.J., 1995, INFECT DIS FETUS NEW, V37, P980
[5]   IMMUNIZATION OF PREGNANT-WOMEN WITH A POLYSACCHARIDE VACCINE OF GROUP-B STREPTOCOCCUS [J].
BAKER, CJ ;
RENCH, MA ;
EDWARDS, MS ;
CARPENTER, RJ ;
HAYS, BM ;
KASPER, DL .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 319 (18) :1180-1185
[6]   Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib [J].
Baker, CJ ;
Paoletti, LC ;
Wessels, MR ;
Guttormsen, HK ;
Rench, MA ;
Hickman, ME ;
Kasper, DL .
JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (01) :142-150
[7]   Use of capsular polysaccharide-tetanus toxoid conjugate vaccine for type II group B Streptococcus in healthy women [J].
Baker, CJ ;
Paoletti, LC ;
Rench, MA ;
Guttormsen, HK ;
Carey, VJ ;
Hickman, ME ;
Kasper, DL .
JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (04) :1129-1138
[8]   Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children [J].
Black, S ;
Shinefield, H ;
Fireman, B ;
Lewis, E ;
Ray, P ;
Hansen, JR ;
Elvin, L ;
Ensor, KM ;
Hackell, J ;
Siber, G ;
Malinoski, F ;
Madore, D ;
Chang, I ;
Kohberger, R ;
Watson, W ;
Austrian, R ;
Edwards, K .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2000, 19 (03) :187-195
[9]  
CARVALHO ADA, 1977, LANCET, V2, P809
[10]  
Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P525